The emerging approach of this peptide represents a exciting advance in the handling of the condition. Different to existing drugs, tirzepatide targets dual pathways – glucagon-like peptide-1 (GLP-1) and GIP – https://tirzepatide-peptide965947.blogsvila.com/42350379/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment